Spin and Charge Correlations in Quantum Dots: An Exact Solution

The inclusion of charging and spin-exchange interactions within the Universal Hamiltonian description of quantum dots is challenging as it leads to a non-Abelian action. Here we present an {\it exact} analytical solution of the probem, in particular, in the vicinity of the Stoner instabilty point. We calculate several observables, including the tunneling density of states (TDOS) and the spin susceptibility. Near the instability point the TDOS exhibits a non-monotonous behavior as function of the tunneling energy, even at temperatures higher than the exchange energy. Our approach is generalizable to a broad set of observables, including the a.c. susceptibility and the absorption spectrum for anisotropic spin interaction. Our results could be tested in nearly ferromagnetic materials.Comment: JETPL class, 6 pages, 2 figure

rural and urban schools northern greece in the interwar period

Modernism—as cultural and artistic expression of modern core values—is often associated with urban and industrial contexts, in stark contrast to a "backward countryside". Focusing on modernist reinventions of the rural landscape, MODSCAPES (funded under HERA JRP III call "Uses of the Past", Oct. 2016–2019) specifically questions these preconceived ideas. In different political and ideological contexts agricultural development schemes carried out in Europe during the twentieth century were pivotal experiments in nation-building policies. In addition, they provided a common testing ground for the ideas, and tools, of environmental and social scientists, architects and engineers, planners and landscape architects, as well as artists. This contribution presents the case study of Northern Greece, focusing on rural and urban schools as a key architectural theme, called upon to express the founding values of a collective identity. The dialectic between tradition and innovation, eclecticism and modernism, uncovers its meaning case by case

On the reliability of mass-loss-rate estimates for AGB stars

In the recent literature there has been some doubt as to the reliability of CO multi-transitional line observations as a mass-loss-rate estimator for AGB stars. Mass-loss rates for 10 intermediate- to high-mass-loss-rate AGB stars are derived using a detailed non-LTE, non-local radiative transfer code based on the Monte-Carlo method to model the CO radio line intensities. The circumstellar envelopes are assumed to be spherically symmetric and formed by constant mass-loss rates. The energy balance is solved self-consistently and the effects of dust on the radiation field and thermal balance are included. An independent estimate of the mass-loss rate is also obtained from the combination of dust radiative transfer modelling with a dynamical model of the gas and dust particles. We find that the CO radio line intensities and shapes are successfully reproduced for the majority of our objects assuming a constant mass-loss rate. Moreover, the CO line intensities are only weakly dependent on the adopted micro-turbulent velocity, in contrast to recent claims in the literature. The two methods used in the present work to derive mass-loss-rates are consistent within a factor of ~3 for intermediate- to high-mass-loss-rate objects, indicating that this is a lower limit to the uncertainty in present mass-loss-rate estimates. We find a tentative trend with chemistry. Mass-loss rates from the dust/dynamical model are systematically higher than those from the CO model for the carbon stars and vice versa for the M-type stars. This could be ascribed to a discrepancy in the adopted CO/H_2-abundance ratio, but we caution that the sample is small and systematic errors cannot be excluded.Comment: 18 pages, 17 figures, accepted for publication in A&

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolising enzyme inducing immune tolerance. The present study aimed to investigate IDO expression and its prognostic significance in endometrial cancer. Indoleamine 2,3-dioxygenase expression in endometrial cancer tissues (n=80) was immunohistochemically scored as four groups (IDO−, 1+, 2+, and 3+). The high IDO expression (IDO2+ or 3+) in tumour cells was found in 37 (46.3%) of the 80 cases, and was positively correlated with surgical stage, myometrial invasion, lymph-vascular space involvement, and lymph node metastasis, but not with the histological grade. Patients with high IDO expression had significantly impaired overall survival and progression-free survival (PFS) (P=0.002 and P=0.001, respectively) compared to patients with no or weak expression of IDO (IDO− or 1+). The 5-year PFS for IDO−/1+, 2+, and 3+ were 97.7, 72.9, and 36.4%, respectively. Even in patients with early-stage disease (International Federation of Gynecology and Obstetrics I/II, n=64), the PFS for IDO2+/3+ was significantly poor (P=0.001) compared to that for IDO−/1+. On multivariate analysis, IDO expression was an independent prognostic factor for PFS (P=0.020). These results indicated that the high IDO expression was involved in the progression of endometrial cancer and correlated with the impaired clinical outcome, suggesting that IDO is a novel and reliable prognostic indicator for endometrial cancer

Evaluation of presumably disease causing SCN1A variants in a cohort of common epilepsy syndromes

Objective: The SCN1A gene, coding for the voltage-gated Na+ channel alpha subunit NaV1.1, is the clinically most relevant epilepsy gene. With the advent of high-throughput next-generation sequencing, clinical laboratories are generating an ever-increasing catalogue of SCN1A variants. Variants are more likely to be classified as pathogenic if they have already been identified previously in a patient with epilepsy. Here, we critically re-evaluate the pathogenicity of this class of variants in a cohort of patients with common epilepsy syndromes and subsequently ask whether a significant fraction of benign variants have been misclassified as pathogenic. Methods: We screened a discovery cohort of 448 patients with a broad range of common genetic epilepsies and 734 controls for previously reported SCN1A mutations that were assumed to be disease causing. We re-evaluated the evidence for pathogenicity of the identified variants using in silico predictions, segregation, original reports, available functional data and assessment of allele frequencies in healthy individuals as well as in a follow up cohort of 777 patients. Results and Interpretation: We identified 8 known missense mutations, previously reported as pathogenic, in a total of 17 unrelated epilepsy patients (17/448; 3.80%). Our re-evaluation indicates that 7 out of these 8 variants (p.R27T; p.R28C; p.R542Q; p.R604H; p.T1250M; p.E1308D; p.R1928G; NP-001159435.1) are not pathogenic. Only the p.T1174S mutation may be considered as a genetic risk factor for epilepsy of small effect size based on the enrichment in patients (P = 6.60 7 10-4; OR = 0.32, fishers exact test), previous functional studies but incomplete penetrance. Thus, incorporation of previous studies in genetic counseling of SCN1A sequencing results is challenging and may produce incorrect conclusions